A Century After Umami#s Discovery, Its Benefits Continue to Expand

Food and Healthcare Press Releases Wednesday July 4, 2018 08:33
TOKYO--4 Jul--PRNewswire/InfoQuest
Latest Umami Research Confirms Appetite Control and Sodium Reduction Benefits

Umami, known as the savory taste, was discovered more than a century ago, yet recent research continues to document the benefits of umami. Currently underway is a year-long recognition of umami's 110th anniversary since its discovery in 1908.

At one event this year, participants at the Asian Congress of Dietetics (ACD) will discuss the latest research on umami, including its dietary significance, during an ACD lunch symposium on Friday, July 6. The symposium ties in directly to the theme of the 7th ACD, which is "The Rise of Nutrition and Dietetics in Asia," being held July 6-8 at the Hong Kong Polytechnic University.

The principal speaker at the lunch symposium will be Dr. Snigdha Misra, who is chair of the Department of Nutrition and Dietetics at International Medical University, in Malaysia. Dr. Snigdha will present the latest research demonstrating that umami improves the palatability of foods and stimulates appetite regulation, supporting nutrition among the elderly. Dr. Snigdha also will discuss how foods with umami seasonings are effective in reducing sodium intake and can help maintain normal blood pressure.

Dr. Snigdha notes, "The elderly face challenges in appetite due to decline in taste sensitivity. The addition of excessive sauces or dressings may make food appetizing, but could be detrimental to health due to the high sodium content. Umami enables food to be flavorful while lowering the sodium content of the food and stimulating appetite."

According to the International Glutamate Information Service (IGIS), sponsor of the symposium, "It is fitting that ACD is focusing on the rise of nutrition in Asia. It was in Japan that   110 years ago Professor Kikunae Ikeda identified the 'glutamic taste' after isolating it from kelp broth. Dr. Ikeda was the first scientist to identify the unique properties of glutamate. He named the taste of glutamate 'umami,' which has a distinctive taste that is different from sweet, sour, bitter, and salty. Umami is now recognized as one of the five basic tastes. Dr. Ikeda's driving goal was to improve nutrition of the Japanese with his umami seasoning."

The IGIS is a non-profit organization communicating science-based information about umami, glutamate, and monosodium glutamate (umami seasoning). For more information, visit glutamate.org.

Latest Press Release

Medical Device Manufacturer Advant Medical Celebrates Its 25th Anniversary

Advant is a successful medical device manufacturer with corporate offices located in Galway, Ireland. For a quarter of a century, Advant has seen significant growth and development expanding into two locations in Ireland, Mexico and Costa Rica. With over...

Michel Orsinger Assumes Role as Chairman of Limacorporate#s Advisory Board

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in...

Merck and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxorubicin (PLD), a type of chemotherapy, compared with PLD did not meet the...

APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

- Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and...

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Related Topics